BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34054795)

  • 1. Latent TGF-β Activation Is a Hallmark of the Tenascin Family.
    Aubert A; Mercier-Gouy P; Aguero S; Berthier L; Liot S; Prigent L; Alcaraz LB; Verrier B; Terreux R; Moali C; Lambert E; Valcourt U
    Front Immunol; 2021; 12():613438. PubMed ID: 34054795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β.
    Alcaraz LB; Exposito JY; Chuvin N; Pommier RM; Cluzel C; Martel S; Sentis S; Bartholin L; Lethias C; Valcourt U
    J Cell Biol; 2014 May; 205(3):409-28. PubMed ID: 24821840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenascin-X: beyond the architectural function.
    Valcourt U; Alcaraz LB; Exposito JY; Lethias C; Bartholin L
    Cell Adh Migr; 2015; 9(1-2):154-65. PubMed ID: 25793578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid requirements for formation of the TGF-beta-latent TGF-beta binding protein complexes.
    Chen Y; Ali T; Todorovic V; O'leary JM; Kristina Downing A; Rifkin DB
    J Mol Biol; 2005 Jan; 345(1):175-86. PubMed ID: 15567420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta.
    Ribeiro SM; Poczatek M; Schultz-Cherry S; Villain M; Murphy-Ullrich JE
    J Biol Chem; 1999 May; 274(19):13586-93. PubMed ID: 10224129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta.
    Saharinen J; Keski-Oja J
    Mol Biol Cell; 2000 Aug; 11(8):2691-704. PubMed ID: 10930463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tryptophan-rich motifs of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor-beta complex.
    Young GD; Murphy-Ullrich JE
    J Biol Chem; 2004 Nov; 279(46):47633-42. PubMed ID: 15342643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1.
    Annes JP; Chen Y; Munger JS; Rifkin DB
    J Cell Biol; 2004 Jun; 165(5):723-34. PubMed ID: 15184403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Tenascin-X in regulating TGF-β/Smad signaling pathway in pathogenesis of slow transit constipation.
    Zhang YC; Chen BX; Xie XY; Zhou Y; Qian Q; Jiang CQ
    World J Gastroenterol; 2020 Feb; 26(7):717-724. PubMed ID: 32116419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of tenascin expression by tissue microenvironments.
    Tucker RP; Chiquet-Ehrismann R
    Biochim Biophys Acta; 2009 May; 1793(5):888-92. PubMed ID: 19162090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent transforming growth factor-beta complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selectin-ligand or MG-160.
    Olofsson A; Hellman U; Ten Dijke P; Grimsby S; Ichijo H; Morén A; Miyazono K; Heldin CH
    Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):427-34. PubMed ID: 9182700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action.
    Saharinen J; Hyytiäinen M; Taipale J; Keski-Oja J
    Cytokine Growth Factor Rev; 1999 Jun; 10(2):99-117. PubMed ID: 10743502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1.
    Saharinen J; Taipale J; Keski-Oja J
    EMBO J; 1996 Jan; 15(2):245-53. PubMed ID: 8617200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
    Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
    Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenascin-Y: a protein of novel domain structure is secreted by differentiated fibroblasts of muscle connective tissue.
    Hagios C; Koch M; Spring J; Chiquet M; Chiquet-Ehrismann R
    J Cell Biol; 1996 Sep; 134(6):1499-512. PubMed ID: 8830777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1.
    Schultz-Cherry S; Chen H; Mosher DF; Misenheimer TM; Krutzsch HC; Roberts DD; Murphy-Ullrich JE
    J Biol Chem; 1995 Mar; 270(13):7304-10. PubMed ID: 7706271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of tenascin genes.
    Chiovaro F; Chiquet-Ehrismann R; Chiquet M
    Cell Adh Migr; 2015; 9(1-2):34-47. PubMed ID: 25793574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1.
    Kalembeyi I; Inada H; Nishiura R; Imanaka-Yoshida K; Sakakura T; Yoshida T
    Int J Cancer; 2003 May; 105(1):53-60. PubMed ID: 12672030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced tenascin-C expression and matrix deposition during Ras/TGF-beta-induced progression of mammary tumor cells.
    Maschler S; Grunert S; Danielopol A; Beug H; Wirl G
    Oncogene; 2004 Apr; 23(20):3622-33. PubMed ID: 15116096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenascin-X Mediates Flow-Induced Suppression of EndMT and Atherosclerosis.
    Liang G; Wang S; Shao J; Jin YJ; Xu L; Yan Y; Günther S; Wang L; Offermanns S
    Circ Res; 2022 May; 130(11):1647-1659. PubMed ID: 35443807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.